参考文献/References:
[1] 宋 哲, 白晓枫, 刘雅刚, 等. 尾型同源盒转录因子通过酪氨酸激酶/信号传导与转录激活因子信号通路抑制胃癌细胞的迁移及侵袭[J]. 中华实验外科杂志, 2017, 34(11):1912-1914.
[2] 杨 瑞, 张晓娟, 梁英健, 等. 普通肝素通过抑制HOXA9表达下调可以减少内皮细胞活化[J]. 中华危重病急救医学, 2018, 30(4):302-305.
[3] Laurent C, Svrcek M, Flejou JF, et al. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer[J]. Inflamm Bowel Dis, 2015, 17(1):232-240.
[4] 刘贵生, 周子涵 ,郭雪艳,等. 同源盒转录因子CDX2与肝肠钙粘连蛋白CDH17在肠上皮化生及胃癌组织中的表达及意义[J]. 陕西医学杂志, 2017, 46(3): 290-293.
[5] 缴 宁, 胡 杰, 赵 彬, 等. 复方苦参注射液联合化疗治疗晚期膀胱癌的临床观察[J].陕西中医,2016,37(7):852-853.
[6] 王训凯, 郑见宝, 孙学军, 等. 尾型同源盒转录因子2 shRNA慢病毒表达载体的构建及其转染对结肠癌细胞生长的影响[J]. 中国普通外科杂志, 2016, 25(4):529-534.
[7] Wrangle J, Machida EO, Danilova L, et al. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer[J]. Clin Cancer Res, 2014, 20(7):1856-1864.
[8] Kameoka Y, Kitazawa R, Ariasu K, et al. Reactivation of CDX2 in gastric cancer as mark for gene silencing memory[J]. Acta Histochem Cytochem, 2015, 48(4):115-124.
[9] 许良璧, 项一宁, 杨浩羿, 等. 糜烂性食管炎、Barrett食管及食管腺癌中SOX2、CDX2的表达及其临床意义[J]. 临床与实验病理学杂志, 2016, 32(9):1014-1018.
[10] 高文青, 李 琪, 陈 蕴, 等. 内部核糖体进入位点(IRES)调控多种癌细胞系中尾型同源盒转录因子2的翻译[J]. 中国生物化学与分子生物学报, 2017, 33(3):260-268.
[11] Bai Y,Akiyama Y,Nagasaki H,et al.Distinct Expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines[J]. Mol Carcinog,2000,28(3):184-188.
[12] 何 娟, 黄 林, 孙 奇, 等. 检测原发性卵巢癌和转移性卵巢癌CDX2、CK7、CA125表达的临床意义[J]. 实用妇产科杂志, 2017, 33(2):141-144.
[13] 孙 丹, 武 洋, 辛 彦. SOX2和CDX2基因编码蛋白在胃癌及其癌前病变中的表达及意义[J]. 现代肿瘤医学, 2016, 24(10):1585-1591.
[14] Malek R, Gajula RP, Williams RD, et al. TWIST1-WDR5-Hottip regulates HOXA9 chromatin to facilitate prostate cancer metastasis[J]. Cancer Res, 2017, 77(12):3181-3193.
[15] Bhatlekar S, Viswanathan V, Fields JZ, et al. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation[J]. J Cell Physiol, 2017, 233(2):727-735.
[16] Heinrichs S, Berman JN, Ortiz TM, et al. CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome[J]. Br J Haematol, 2015, 130(1):83-86.
[17] 李 琳, 赵春亭, 崔渤莉, 等. HOXB4、PRDM16及HOXA9在急性髓系白血病中的表达及临床意义[J]. 中国实验血液学杂志, 2016, 24(2):326-331.
[18] 谢忻琰, 邵宗鸿, 付 蓉, 等. HOXA9在骨髓增生异常综合征中的表达及意义[J]. 中国实验血液学杂志, 2016, 24(4):1100-1103.
[19] Ko SY, Ladanyi A, Lengyel E, et al. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype[J]. Am J Pathol, 2014, 184(1):271-281.